Richard M. Scearce spends much of his time researching Virology, Antibody, Epitope, Molecular biology and Monoclonal antibody. The study incorporates disciplines such as Immunogen, Immunology and Immunogenicity in addition to Virology. He has researched Antibody in several fields, including Immune system, Glycoprotein and Vaccination.
His Vaccination research incorporates themes from Mutation and Neutralization. His Epitope study frequently involves adjacent topics like Virus. His Neutralizing antibody study combines topics from a wide range of disciplines, such as T cell, B cell and Antigen.
Richard M. Scearce mostly deals with Antibody, Virology, Molecular biology, Monoclonal antibody and Epitope. Richard M. Scearce has included themes like T cell, Antigen and Vaccination in his Antibody study. Richard M. Scearce mostly deals with Virus in his studies of Virology.
His Molecular biology research is multidisciplinary, incorporating perspectives in Receptor, breakpoint cluster region, Ligand, Protein structure and Naive B cell. His Monoclonal antibody research integrates issues from Epithelium, Western blot, Cellular differentiation and Glycoprotein. His study explores the link between Epitope and topics such as Peptide sequence that cross with problems in Amino acid.
His primary areas of investigation include Antibody, Virology, Immunization, Vaccination and Recombinant DNA. The Antibody study combines topics in areas such as Molecular biology, Naive B cell and Immune system. His Virology research is multidisciplinary, relying on both Immunology, Glycan, Epitope and Immunogen, Monoclonal antibody.
The various areas that Richard M. Scearce examines in his Epitope study include Immunoglobulin heavy chain, Glutamic acid and Aspartic acid. He studied Vaccination and HIV vaccine that intersect with Viremia, Immunogenicity, Vaccine trial and Simian immunodeficiency virus. His Neutralizing antibody research is multidisciplinary, incorporating elements of Antigen and Affinity maturation.
Antibody, Virology, Immunization, Vaccination and Immunogen are his primary areas of study. His Antibody research includes elements of Molecular biology, Binding site and Antigen. The Molecular biology study combines topics in areas such as T cell, Immune system, Affinity maturation and Germinal center, B cell.
His studies in Binding site integrate themes in fields like HIV vaccine and Heterologous. His work on Viral Vaccine as part of general Vaccination study is frequently linked to Pandemic, bridging the gap between disciplines. His Immunogen research incorporates themes from Recombinant DNA, Pentavalent vaccine, Antibody-dependent cell-mediated cytotoxicity, Vaccine efficacy and Serology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
Hua-Xin Liao;Rebecca Lynch;Tongqing Zhou;Feng Gao;Feng Gao.
Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies
Barton F. Haynes;Judith Fleming;E. William St. Clair;Herman Katinger.
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
Norbert Pardi;Michael J. Hogan;Rebecca S. Pelc;Hiromi Muramatsu.
The Role of Antibody Polyspecificity and Lipid Reactivity in Binding of Broadly Neutralizing Anti-HIV-1 Envelope Human Monoclonal Antibodies 2F5 and 4E10 to Glycoprotein 41 Membrane Proximal Envelope Epitopes
S. Munir Alam;Mildred McAdams;David Boren;Michael Rak.
Journal of Immunology (2007)
A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses.
Hua Xin Liao;Laura L. Sutherland;Shi Mao Xia;Mary E. Brock.
Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses.
Norbert Pardi;Michael J. Hogan;Martin S. Naradikian;Kaela Parkhouse.
Journal of Experimental Medicine (2018)
Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group M consensus envelope glycoprotein
Feng Gao;Eric A. Weaver;Zhongjing Lu;Yingying Li.
Journal of Virology (2005)
Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes.
T J Palker;T J Matthews;A Langlois;M E Tanner.
Journal of Immunology (1989)
Human Immunodeficiency Virus Type 1 gp41 Antibodies That Mask Membrane Proximal Region Epitopes: Antibody Binding Kinetics, Induction, and Potential for Regulation in Acute Infection
S. Munir Alam;Richard M. Scearce;Robert J. Parks;Kelly Plonk.
Journal of Virology (2008)
Phenotypic characterization and ontogeny of mesodermal-derived and endocrine epithelial components of the human thymic microenvironment.
B F Haynes;R M Scearce;D F Lobach;L L Hensley.
Journal of Experimental Medicine (1984)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: